
Standard Chem & Pharm Co Ltd
TWSE:1720

Standard Chem & Pharm Co Ltd?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
60.6
78.7
|
Price Target |
|
We'll email you a reminder when the closing price reaches TWD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Standard Chem & Pharm Co Ltd hold over its rivals?
What risks and challenges
does Standard Chem & Pharm Co Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Standard Chem & Pharm Co Ltd.
Provide an overview of the primary business activities
of Standard Chem & Pharm Co Ltd.
What unique competitive advantages
does Standard Chem & Pharm Co Ltd hold over its rivals?
What risks and challenges
does Standard Chem & Pharm Co Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Standard Chem & Pharm Co Ltd.
Provide P/S
for Standard Chem & Pharm Co Ltd.
Provide P/E
for Standard Chem & Pharm Co Ltd.
Provide P/OCF
for Standard Chem & Pharm Co Ltd.
Provide P/FCFE
for Standard Chem & Pharm Co Ltd.
Provide P/B
for Standard Chem & Pharm Co Ltd.
Provide EV/S
for Standard Chem & Pharm Co Ltd.
Provide EV/GP
for Standard Chem & Pharm Co Ltd.
Provide EV/EBITDA
for Standard Chem & Pharm Co Ltd.
Provide EV/EBIT
for Standard Chem & Pharm Co Ltd.
Provide EV/OCF
for Standard Chem & Pharm Co Ltd.
Provide EV/FCFF
for Standard Chem & Pharm Co Ltd.
Provide EV/IC
for Standard Chem & Pharm Co Ltd.
Show me price targets
for Standard Chem & Pharm Co Ltd made by professional analysts.
What are the Revenue projections
for Standard Chem & Pharm Co Ltd?
How accurate were the past Revenue estimates
for Standard Chem & Pharm Co Ltd?
What are the Net Income projections
for Standard Chem & Pharm Co Ltd?
How accurate were the past Net Income estimates
for Standard Chem & Pharm Co Ltd?
What are the EPS projections
for Standard Chem & Pharm Co Ltd?
How accurate were the past EPS estimates
for Standard Chem & Pharm Co Ltd?
What are the EBIT projections
for Standard Chem & Pharm Co Ltd?
How accurate were the past EBIT estimates
for Standard Chem & Pharm Co Ltd?
Compare the revenue forecasts
for Standard Chem & Pharm Co Ltd with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Standard Chem & Pharm Co Ltd and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Standard Chem & Pharm Co Ltd against its competitors.
Analyze the profit margins
(gross, operating, and net) of Standard Chem & Pharm Co Ltd compared to its peers.
Compare the P/E ratios
of Standard Chem & Pharm Co Ltd against its peers.
Discuss the investment returns and shareholder value creation
comparing Standard Chem & Pharm Co Ltd with its peers.
Analyze the financial leverage
of Standard Chem & Pharm Co Ltd compared to its main competitors.
Show all profitability ratios
for Standard Chem & Pharm Co Ltd.
Provide ROE
for Standard Chem & Pharm Co Ltd.
Provide ROA
for Standard Chem & Pharm Co Ltd.
Provide ROIC
for Standard Chem & Pharm Co Ltd.
Provide ROCE
for Standard Chem & Pharm Co Ltd.
Provide Gross Margin
for Standard Chem & Pharm Co Ltd.
Provide Operating Margin
for Standard Chem & Pharm Co Ltd.
Provide Net Margin
for Standard Chem & Pharm Co Ltd.
Provide FCF Margin
for Standard Chem & Pharm Co Ltd.
Show all solvency ratios
for Standard Chem & Pharm Co Ltd.
Provide D/E Ratio
for Standard Chem & Pharm Co Ltd.
Provide D/A Ratio
for Standard Chem & Pharm Co Ltd.
Provide Interest Coverage Ratio
for Standard Chem & Pharm Co Ltd.
Provide Altman Z-Score Ratio
for Standard Chem & Pharm Co Ltd.
Provide Quick Ratio
for Standard Chem & Pharm Co Ltd.
Provide Current Ratio
for Standard Chem & Pharm Co Ltd.
Provide Cash Ratio
for Standard Chem & Pharm Co Ltd.
What is the historical Revenue growth
over the last 5 years for Standard Chem & Pharm Co Ltd?
What is the historical Net Income growth
over the last 5 years for Standard Chem & Pharm Co Ltd?
What is the current Free Cash Flow
of Standard Chem & Pharm Co Ltd?
Discuss the annual earnings per share (EPS)
trend over the past five years for Standard Chem & Pharm Co Ltd.
P/E
Price to Earnings
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
Market Cap | P/E | ||||
---|---|---|---|---|---|
TW |
![]() |
Standard Chem & Pharm Co Ltd
TWSE:1720
|
11.3B TWD | 13.3 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
793.6B USD | 74.9 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | -15 783.5 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
393.8B USD | 28 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
2.3T DKK | 23.3 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
246.5B CHF | 21.4 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
235.8B USD | 13.8 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
180B GBP | 33.1 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
200.9B CHF | 19.1 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
166.1B USD | -56.8 |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
148.9B USD | 18.5 |
|
Earnings Growth | PEG | |||||
---|---|---|---|---|---|---|
TW |
![]() |
Standard Chem & Pharm Co Ltd
TWSE:1720
|
Average P/E:
27.3
13.3
|
N/A | N/A | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
74.9
|
48%
|
1.6 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
Negative Multiple: -15 783.5 | N/A | N/A |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
28
|
26%
|
1.1 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
23.3
|
19%
|
1.2 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
21.4
|
16%
|
1.3 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
13.8
|
17%
|
0.8 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
33.1
|
36%
|
0.9 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
19.1
|
16%
|
1.2 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
Negative Multiple: -56.8 | N/A | N/A |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
18.5
|
29%
|
0.6 |
|
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.